Equity Screeners to view more equity screening toolsLa Jolla earnings-per-share fundamental analysis lookup allows you to check this and other indicators for La Jolla Pharmaceutical Company or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also
La Jolla Earnings Per Share AnalysisEarnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
|La Jolla||Earnings Per Share||=|
La Jolla Earnings Per Share Over Time Pattern
La Jolla Earnings per Diluted Share
About Earnings Per ShareEarnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.
|Compare to competition|
La Jolla Earnings Per Share Assessment
According to company disclosure La Jolla Pharmaceutical Company has Earnings Per Share of -5.92 times. This is 170.73% lower than that of the Healthcare sector, and 23.59% higher than that of Biotechnology industry, The Earnings Per Share for all stocks is 289.74% higher than the company.
La Jolla Earnings Per Share Peer Comparison
La Jolla is currently under evaluation in earnings per share category among related companies.
La Jolla current financial ratios
|Return On Equity||(307.09)%|
|Return On Asset||(40.87)%|
|Shares Owned by Insiders||6.08%|
|Shares Owned by Institutions||104.64%|
|Number of Shares Shorted||5.65M|
|Price to Earning||(6.45)X|
|Price to Book||30.11X|
|Price to Sales||16.38X|
|Cash and Equivalents||123.45M|
|Cash per Share||4.55X|
|Book Value Per Share||(0.61)X|
|Cash Flow from Operations||(118.15M)|
|Earnings Per Share||(5.92)X|
|Price to Earnings To Growth||(0.16)X|
|Number of Employees||169|